Home › Diffuse Scleroderma › Tennessee
Diffuse Scleroderma clinical trials in Tennessee
4 studies for Diffuse Scleroderma are looking for participants at sites in Tennessee.
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
- West Tennessee Research Institute, Jackson
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 28, 2026 · NCT06470048Platform Clinical Study for Conquering Scleroderma
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Hixson, Hixson
- Artiva Investigational Site Jackson, Jackson
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06991114The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 and older · All sexes · Updated Jan 8, 2026 · NCT06675344From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.